Dr. Greg Marchand Named to the Fulbright Specialist Roster by the U.S. Department of State
FOR IMMEDIATE RELEASE
MESA, Ariz. — July 16, 2023
Dr. Greg Marchand and the Marchand Institute for Minimally Invasive Surgery is excited to have published the largest study ever performed investigating the effects of COVID19 vaccinations in pregnancy. This study looked at the affect these vaccinations had on the health of both mother and baby, and how effective these vaccines were are preventing COVID19 infection in mothers and babies as well. The full paper is available online at the journal’s website at: https://www.nature.com/articles/s41541-023-00698-8, as well as available on the pubmed government site here: https://pubmed.ncbi.nlm.nih.gov/37454153/.
About Dr. Greg Marchand
Greg J. Marchand, MD, FACS, FACOG, FICS, is a dual board-certified obstetrician-gynecologist and minimally invasive gynecologic surgeon practising in Mesa, Arizona. He holds the ABOG Focused Practice Designation in Minimally Invasive Gynecologic Surgery and directs the Marchand Institute for Minimally Invasive Surgery, a 501(c)(3) tax-exempt non-profit research and educational corporation (EIN 42-2857240). He is Program Director of an SLS-accredited fellowship in Minimally Invasive and Robotic Gynecologic Surgery, holds three issued United States patents, and has served as Principal Investigator on eight FDA clinical trials. His systematic reviews are prospectively registered with PROSPERO, reported to PRISMA standards and appraised with the Cochrane Risk of Bias 2 tool. He accepts no industry funding for his research.
Media Contact
Maria A. Sainz
Director of Communications and Media Relations
maria@marchandobgyn.com
(480) 999-0905
Newsroom and press kit · Full publication list · Research methodology · Expert commentary topics
###
Related posts
